MedTrace Logo

Impaired Glucose Tolerance and Cognition in MS

NCT04748302 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2021-02-10

No results posted yet for this study

Summary

This is a pilot study to compare cognitive performance in two groups of subjects with multiple sclerosis; those with normal glucose tolerance and those with impaired glucose tolerance. The study consists of a 2 hour oral glucose tolerance test, patient reported outcomes, a series of cognitive functioning tests, and outpatient physical assessment using a pedometer.

Conditions

Sponsors & Collaborators

  • University of Virginia

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-06
Primary Completion
2020-04-01
Completion
2020-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04748302 on ClinicalTrials.gov